This topic contains a solution. Click here to go to the answer

Author Question: Most MCP contracts with providers are on a shared-risk basis. Indicate whether this statement is ... (Read 68 times)

danielfitts88

  • Hero Member
  • *****
  • Posts: 535
Most MCP contracts with providers are on a shared-risk basis.
 
  Indicate whether this statement is true or false.

Question 2

All denial letters must meet which of the following criteria?
 
  a. The decision to deny must be correct and based upon approved medical practices.
  b. The denial reason must be kept private to protect the member.
  c. HMO-approved denial reasons must be used.
  d. The denial letter must be sent to the member's parents.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

kmb352

  • Sr. Member
  • ****
  • Posts: 319
Answer to Question 1

Answer: T

Answer to Question 2

A




danielfitts88

  • Member
  • Posts: 535
Reply 2 on: Jun 27, 2018
Excellent


raili21

  • Member
  • Posts: 324
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

Approximately one in three babies in the United States is now delivered by cesarean section. The number of cesarean sections in the United States has risen 46% since 1996.

Did you know?

Famous people who died from poisoning or drug overdose include, Adolf Hitler, Socrates, Juan Ponce de Leon, Marilyn Monroe, Judy Garland, and John Belushi.

Did you know?

Though newer “smart” infusion pumps are increasingly becoming more sophisticated, they cannot prevent all programming and administration errors. Health care professionals that use smart infusion pumps must still practice the rights of medication administration and have other professionals double-check all high-risk infusions.

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

For a complete list of videos, visit our video library